Pharbil Waltrop

Pharbil Waltrop, operating as a primary manufacturing facility for NextPharma, is a Contract Development and Manufacturing Organization (CDMO) based in Waltrop, Germany. The site specializes in the production of oral solid dosage forms, including tablets, film-coated tablets, and hard gelatin capsules, as well as non-sterile liquid and semi-solid formulations. Its services encompass the entire product lifecycle, from pharmaceutical development and clinical trial material manufacturing to large-scale commercial production and specialized packaging. The facility is EU-GMP certified and maintains high-quality standards to serve international pharmaceutical and healthcare clients. As a center of excellence within the NextPharma network, it provides critical supply chain solutions for both global pharma companies and mid-sized biotech firms.